New Developments in Myocardial Perfusion Imaging: Technetium 99mtc Sestamibi
Seiten
1992
Taylor & Francis Ltd (Verlag)
978-1-85317-098-0 (ISBN)
Taylor & Francis Ltd (Verlag)
978-1-85317-098-0 (ISBN)
- Titel wird leider nicht erscheinen
- Artikel merken
Examines the advantages of technetium 99mTc Sestamibi and its use in the diagnosis, management and prognosis of coronary artery disease. The book is aimed at nuclear cardiologists and specialists in nuclear medicine and nuclear radiologists.
Myocardial imaging plays an increasingly important role in the non-invasive diagnosis and management of coronary heart disease. Technetium 99mTc Sestamibi is a new perfusion imaging agent whose improved sensitivity and specificity give it some important advantages over thallium-201, until recently the standard clinical method for investigating myocardial perfusion. This book examines the advantages of technetium 99mTc Sestamibi and its use in the diagnosis, management and prognosis of coronary artery disease. The book is aimed at nuclear cardiologists and specialists in nuclear medicine and nuclear radiologists.
Myocardial imaging plays an increasingly important role in the non-invasive diagnosis and management of coronary heart disease. Technetium 99mTc Sestamibi is a new perfusion imaging agent whose improved sensitivity and specificity give it some important advantages over thallium-201, until recently the standard clinical method for investigating myocardial perfusion. This book examines the advantages of technetium 99mTc Sestamibi and its use in the diagnosis, management and prognosis of coronary artery disease. The book is aimed at nuclear cardiologists and specialists in nuclear medicine and nuclear radiologists.
Introduction to the basis of nuclear cardiology and technetium 99mTc Sestamibi; the basis of imaging; diagnosis of CAD; definition of extent of CAD (single vessel versus multiple vessel disease with and without infarct); assessment of functional significance of angiographic lesions; differential diagnosis of acute chest pain; assessment of intervention with PTCA; assessment of the effectiveness of CABG; assessment of myocardial infarction patients; assessment of post-MI patient; assessment of the efficacy of thrombolysis; prognosis; technetium 99mTc Sestamibi as a clinical research tool.
| Erscheint lt. Verlag | 30.10.1992 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Maße | 226 x 297 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Nuklearmedizin | |
| ISBN-10 | 1-85317-098-4 / 1853170984 |
| ISBN-13 | 978-1-85317-098-0 / 9781853170980 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
in Fällen, Fragen und Antworten
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände
Buch (2024)
Deutscher Ärzteverlag
CHF 489,95
Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 61,60
